NCT03548597
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +13 more
- Locations
-
Not specified
Clinical trial condition
Liver Diseases
Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.
8,408 public trials
1,309 recruiting studies
Liver Diseases trial results
NCT00611559
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
- Locations
-
- GSK Investigational Site Murmansk, Russia
- GSK Investigational Site Perm, Russia
- GSK Investigational Site Syktyvkar, Russia
NCT00169442
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
- GSK Investigational Site Pasay, Philippines
- GSK Investigational Site Quezon City, Philippines
NCT01333813
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Oberstenfeld, Baden-Wurttemberg, Germany
- GSK Investigational Site Stuttgart, Baden-Wurttemberg, Germany
NCT00627458
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Jarvenpaa, Finland
- GSK Investigational Site Oulu, Finland
- GSK Investigational Site Pori, Finland
- GSK Investigational Site Tampere, Finland
NCT00158756
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site Barnaul, Russia
- GSK Investigational Site Ivanteevka Moscow Region, Russia
- GSK Investigational Site Krasnoyarsk, Russia
- GSK Investigational Site Moscow, Russia
NCT02023099
- Conditions
- Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +9 more
- Locations
-
Not specified
NCT02965560
- Conditions
- Acute-On-Chronic Liver Failure, Cirrhosis and Chronic Liver Disease, Digestive System Diseases, +7 more
- Locations
-
Not specified
Completed
Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
NCT00317109
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
- Locations
-
- GSK Investigational Site Brits, South Africa
- GSK Investigational Site Ga-Rankuwa, South Africa
- GSK Investigational Site Rooihuiskraal, South Africa
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany
- GSK Investigational Site Bindlach, Bavaria, Germany
- GSK Investigational Site Goch, North Rhine-Westphalia, Germany